Paul-Henri Wicky

2.0k total citations
15 papers, 244 citations indexed

About

Paul-Henri Wicky is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Paul-Henri Wicky has authored 15 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Epidemiology and 4 papers in Pharmacology. Recurrent topics in Paul-Henri Wicky's work include COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Pneumonia and Respiratory Infections (4 papers). Paul-Henri Wicky is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Pneumonia and Respiratory Infections (4 papers). Paul-Henri Wicky collaborates with scholars based in France, Switzerland and Ireland. Paul-Henri Wicky's co-authors include Jean‐François Timsit, Étienne de Montmollin, Juliette Patrier, Stéphane Ruckly, Niccolò Buetti, Pierre Jaquet, Benoît Visseaux, Quentin Le Hingrat, Yazdan Yazdanpanah and Lila Bouadma and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Paul-Henri Wicky

14 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul-Henri Wicky France 11 134 60 53 39 37 15 244
Francesca Cancelli Italy 10 103 0.8× 72 1.2× 46 0.9× 24 0.6× 65 1.8× 20 258
Cristina de la Calle Spain 8 143 1.1× 92 1.5× 36 0.7× 24 0.6× 58 1.6× 14 274
Joanne Daghfal Qatar 7 238 1.8× 40 0.7× 140 2.6× 25 0.6× 19 0.5× 14 324
Jan‐Erik Berdal Norway 8 96 0.7× 94 1.6× 25 0.5× 33 0.8× 13 0.4× 16 252
Karla M. Tamez‐Torres Mexico 8 121 0.9× 49 0.8× 65 1.2× 24 0.6× 15 0.4× 23 217
Michel F. Martínez‐Reséndez Mexico 8 131 1.0× 101 1.7× 12 0.2× 31 0.8× 26 0.7× 29 222
Giulia Pruccoli Italy 8 92 0.7× 37 0.6× 39 0.7× 47 1.2× 12 0.3× 18 223
Kévin Alexandre France 10 61 0.5× 67 1.1× 60 1.1× 81 2.1× 108 2.9× 23 316
Arta Karruli Italy 9 109 0.8× 68 1.1× 60 1.1× 38 1.0× 106 2.9× 18 284
Pınar Aysert Yıldız Türkiye 7 126 0.9× 35 0.6× 66 1.2× 58 1.5× 17 0.5× 20 217

Countries citing papers authored by Paul-Henri Wicky

Since Specialization
Citations

This map shows the geographic impact of Paul-Henri Wicky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul-Henri Wicky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul-Henri Wicky more than expected).

Fields of papers citing papers by Paul-Henri Wicky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul-Henri Wicky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul-Henri Wicky. The network helps show where Paul-Henri Wicky may publish in the future.

Co-authorship network of co-authors of Paul-Henri Wicky

This figure shows the co-authorship network connecting the top 25 collaborators of Paul-Henri Wicky. A scholar is included among the top collaborators of Paul-Henri Wicky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul-Henri Wicky. Paul-Henri Wicky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
4.
Montmollin, Étienne de, Katell Peoc’h, Mehdi Marzouk, et al.. (2022). Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS. Antibiotics. 11(9). 1166–1166. 6 indexed citations
5.
Granger, Vanessa, Paul-Henri Wicky, Jean‐François Timsit, et al.. (2022). Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19. Scientific Reports. 12(1). 638–638. 27 indexed citations
6.
Lolom, Isabelle, Marie Petitjean, Emilie Rondinaud, et al.. (2022). Simultaneous Hospital Outbreaks of New Delhi Metallo-β-Lactamase-Producing Enterobacterales Unraveled Using Whole-Genome Sequencing. Microbiology Spectrum. 10(2). e0228721–e0228721. 5 indexed citations
7.
Wicky, Paul-Henri, Ignacio Martín‐Loeches, & Jean‐François Timsit. (2022). HAP and VAP after Guidelines. Seminars in Respiratory and Critical Care Medicine. 43(2). 248–254. 4 indexed citations
8.
Timsit, Jean‐François, Paul-Henri Wicky, & Étienne de Montmollin. (2022). Treatment of Severe Infections Due to Metallo-Betalactamases Enterobacterales in Critically Ill Patients. Antibiotics. 11(2). 144–144. 15 indexed citations
9.
Meyer, Antoine, Niccolò Buetti, Nadhira Houhou‐Fidouh, et al.. (2021). HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients. Critical Care. 25(1). 417–417. 38 indexed citations
10.
Lê, Minh, Quentin Le Hingrat, Pierre Jaquet, et al.. (2020). Removal of Remdesivir’s Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19. Antimicrobial Agents and Chemotherapy. 64(11). 16 indexed citations
11.
Lê, Minh, Pierre Jaquet, Juliette Patrier, et al.. (2020). Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients. Journal of Antimicrobial Chemotherapy. 75(9). 2657–2660. 11 indexed citations
12.
Bouiller, Kévin, et al.. (2020). Spread of clonal linezolid-resistant Staphylococcus epidermidis in an intensive care unit associated with linezolid exposure. European Journal of Clinical Microbiology & Infectious Diseases. 39(7). 1271–1277. 11 indexed citations
13.
Buetti, Niccolò, Paul-Henri Wicky, Quentin Le Hingrat, et al.. (2020). SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients. Critical Care. 24(1). 610–610. 17 indexed citations
14.
Bouadma, Lila, Aurélie Wiedemann, Juliette Patrier, et al.. (2020). Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome. Journal of Clinical Immunology. 40(8). 1082–1092. 35 indexed citations
15.
Dubert, Marie, Benoît Visseaux, Valentina Isernia, et al.. (2020). Case report study of the first five COVID-19 patients treated with remdesivir in France. International Journal of Infectious Diseases. 98. 290–293. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Cancelli Breakdown of academic impact, for papers by Cristina de la Calle Breakdown of academic impact, for papers by Joanne Daghfal Breakdown of academic impact, for papers by Jan‐Erik Berdal Breakdown of academic impact, for papers by Karla M. Tamez‐Torres Breakdown of academic impact, for papers by Michel F. Martínez‐Reséndez Breakdown of academic impact, for papers by Giulia Pruccoli Breakdown of academic impact, for papers by Kévin Alexandre Breakdown of academic impact, for papers by Arta Karruli Breakdown of academic impact, for papers by Pınar Aysert Yıldız
Rankless by CCL
2026